Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Westphal

Showing results (211-220 of 309) with videos related to

Pageof 31
Sort By:
Journal of Cancer Research and Clinical Oncology|November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastomaKatharina Seystahl, Bettina Hentschel, Sarah Loew, et al.
Neuro-Oncology Practice|July 19, 2021
Chemotherapy for adult patients with spinal cord gliomasDorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Cancers|December 22, 2018
Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic DiseaseAnnkathrin Hanssen, Carlotta Riebensahm, Malte Mohme, et al.
Neurobiology of Disease|September 29, 2020
Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivoMagdalena K Baaske, Eszter Kormann, Abbey B Holt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 3, 2014
Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's diseaseAndrew Sharott, Alessandro Gulberti, Simone Zittel, et al.
Public Health Genomics|May 31, 2016
Gene-Tailored Treatments for Brain Disorders: Challenges and OpportunitiesGiovanni Esposito, Jean Marc Burgunder, John Dunlop, et al.
Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.
Breast Cancer Research : BCR|March 21, 2012
Relevance of PTEN loss in brain metastasis formation in breast cancer patientsHarriet Wikman, Katrin Lamszus, Niclas Detels, et al.
International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
International Journal of Molecular Sciences|March 18, 2020
FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular VesiclesFranz L Ricklefs, Cecile L Maire, Jakob Matschke, et al.
Pageof 31

Showing results (211-220 of 309) with videos related to

Sort By:
Pageof 31
Journal of Cancer Research and Clinical Oncology|November 23, 2019
Bevacizumab versus alkylating chemotherapy in recurrent glioblastomaKatharina Seystahl, Bettina Hentschel, Sarah Loew, et al.
Neuro-Oncology Practice|July 19, 2021
Chemotherapy for adult patients with spinal cord gliomasDorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Cancers|December 22, 2018
Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic DiseaseAnnkathrin Hanssen, Carlotta Riebensahm, Malte Mohme, et al.
Neurobiology of Disease|September 29, 2020
Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivoMagdalena K Baaske, Eszter Kormann, Abbey B Holt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 3, 2014
Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's diseaseAndrew Sharott, Alessandro Gulberti, Simone Zittel, et al.
Public Health Genomics|May 31, 2016
Gene-Tailored Treatments for Brain Disorders: Challenges and OpportunitiesGiovanni Esposito, Jean Marc Burgunder, John Dunlop, et al.
Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.
Breast Cancer Research : BCR|March 21, 2012
Relevance of PTEN loss in brain metastasis formation in breast cancer patientsHarriet Wikman, Katrin Lamszus, Niclas Detels, et al.
International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
International Journal of Molecular Sciences|March 18, 2020
FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular VesiclesFranz L Ricklefs, Cecile L Maire, Jakob Matschke, et al.
Pageof 31